MedPath

Efficacy of hangekobokuto, a representative Kampo(Japanese herbal medicine) formula for Ki congestion, in tinnitus that continues for three months or more: A Randomized, Double-blind, Placebo-Controlled Trial.

Phase 4
Conditions
Tinnitus
Registration Number
JPRN-UMIN000004766
Lead Sponsor
Kitasato University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
112
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients currently taking any Kampo medicine. 2. Patients having taken any Kampo medicine in the post 4 weeks. 3. Objective tinnitus, pulsatile tinnitus. 4. Patients whose air bone gap is equal to or more than 15dB. 5. Patients with clinically significant liver or renal dysfunction. 6. Patients while being getting pregnant and suckling. 7. Patients with some diseases which might influence there general condition, for example, cancer or heart failure. 8. Patients considered inappropriate for this trial by the physicians-in-charge.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
THI(Tinnitus Handicap Inventory)
Secondary Outcome Measures
NameTimeMethod
1. Pure Tone Audiometry 2. VAS(Visual Analogue Scale) 3. SF-36(MOS Short-Form 36-Item Health Survey) 4. HADS(Hospital Anxiety and Depression Scale)
© Copyright 2025. All Rights Reserved by MedPath